Pharma in brief image

Current directions in regulatory and intellectual property law in Canadian pharmaceutical cases

Global Publication April 2016

Recent pharmaceutical cases in regulatory and intellectual property law have resulted in developments on several fronts, including:

  • regulatory matters;
  • patent validity and damages;
  • Patented Medicines (Notice of Compliance) Regulations proceedings; and
  • class actions.

In this paper, we review some of the most notable Canadian decisions from 2015 that will continue to impact the legal landscape for the pharmaceutical industry in Canada over the coming year.

Download the brochure here: 2015 Pharma in Brief (pdf 2.15MB)

Recent publications

Subscribe and stay up to date with the latest legal news, information and events...